BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32950863)

  • 1. The white matter hyperintensities within the cholinergic pathways and cognitive performance in patients with Parkinson's disease after bilateral STN DBS.
    Liu Y; Wu L; Yang C; Xian W; Zheng Y; Zhang C; Hong G; Jiang L; Yang Z; Pei Z; Liu J; Chen L
    J Neurol Sci; 2020 Nov; 418():117121. PubMed ID: 32950863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease.
    Xu D; Yu X; Hu J; Yu Y; Wang L; Jiang B; Zhang M
    Eur Radiol; 2024 Jul; 34(7):4596-4606. PubMed ID: 38092950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of white matter lesions on the cognitive outcome of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Blume J; Lange M; Rothenfusser E; Doenitz C; Bogdahn U; Brawanski A; Schlaier J
    Clin Neurol Neurosurg; 2017 Aug; 159():87-92. PubMed ID: 28582689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical white matter hyperintensities within the cholinergic pathways of Parkinson's disease patients according to cognitive status.
    Shin J; Choi S; Lee JE; Lee HS; Sohn YH; Lee PH
    J Neurol Neurosurg Psychiatry; 2012 Mar; 83(3):315-21. PubMed ID: 22228726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longterm outcome of cognition, affective state, and quality of life following subthalamic deep brain stimulation in Parkinson's disease.
    Gruber D; Calmbach L; Kühn AA; Krause P; Kopp UA; Schneider GH; Kupsch A
    J Neural Transm (Vienna); 2019 Mar; 126(3):309-318. PubMed ID: 30684055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive predictors of cognitive change following bilateral subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Yágüez L; Costello A; Moriarty J; Hulse N; Selway R; Clough C; Samuel M; Ashkan K
    J Clin Neurosci; 2014 Mar; 21(3):445-50. PubMed ID: 24231557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson's disease.
    Sunwoo MK; Jeon S; Ham JH; Hong JY; Lee JE; Lee JM; Sohn YH; Lee PH
    Eur J Neurol; 2014 Jun; 21(6):922-e50. PubMed ID: 24661277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreasing subthalamic deep brain stimulation frequency reverses cognitive interference during gait initiation in Parkinson's disease.
    Varriale P; Collomb-Clerc A; Van Hamme A; Perrochon A; Kemoun G; Sorrentino G; George N; Lau B; Karachi C; Welter ML
    Clin Neurophysiol; 2018 Nov; 129(11):2482-2491. PubMed ID: 30100532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of unilateral and bilateral subthalamic nucleus deep brain stimulation on gait kinematics in Parkinson's disease: a randomized, blinded study.
    Lizarraga KJ; Jagid JR; Luca CC
    J Neurol; 2016 Aug; 263(8):1652-6. PubMed ID: 27278062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guideline on Subthalamic Nucleus and Globus Pallidus Internus Deep Brain Stimulation for the Treatment of Patients With Parkinson's Disease: Executive Summary.
    Rughani A; Schwalb JM; Sidiropoulos C; Pilitsis J; Ramirez-Zamora A; Sweet JA; Mittal S; Espay AJ; Martinez JG; Abosch A; Eskandar E; Gross R; Alterman R; Hamani C
    Neurosurgery; 2018 Jun; 82(6):753-756. PubMed ID: 29538685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional SPACE fluid-attenuated inversion recovery at 3 T to improve subthalamic nucleus lead placement for deep brain stimulation in Parkinson's disease: from preclinical to clinical studies.
    Senova S; Hosomi K; Gurruchaga JM; Gouello G; Ouerchefani N; Beaugendre Y; Lepetit H; Lefaucheur JP; Badin RA; Dauguet J; Jan C; Hantraye P; Brugières P; Palfi S
    J Neurosurg; 2016 Aug; 125(2):472-80. PubMed ID: 26745490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subthalamic Nucleus Deep Brain Stimulation Modulate Catecholamine Levels with Significant Relations to Clinical Outcome after Surgery in Patients with Parkinson's Disease.
    Yamamoto T; Uchiyama T; Higuchi Y; Asahina M; Hirano S; Yamanaka Y; Kuwabara S
    PLoS One; 2015; 10(9):e0138462. PubMed ID: 26394059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White matter tracts involved by deep brain stimulation of the subthalamic nucleus in Parkinson's disease: a connectivity study based on preoperative diffusion tensor imaging tractography.
    Vassal F; Dilly D; Boutet C; Bertholon F; Charier D; Pommier B
    Br J Neurosurg; 2020 Apr; 34(2):187-195. PubMed ID: 31833430
    [No Abstract]   [Full Text] [Related]  

  • 15. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.
    Drapier S; Raoul S; Drapier D; Leray E; Lallement F; Rivier I; Sauleau P; Lajat Y; Edan G; Vérin M
    J Neurol; 2005 May; 252(5):583-8. PubMed ID: 15778909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deep brain stimulation and cognitive decline in Parkinson's disease: The predictive value of electroencephalography.
    Markser A; Maier F; Lewis CJ; Dembek TA; Pedrosa D; Eggers C; Timmermann L; Kalbe E; Fink GR; Burghaus L
    J Neurol; 2015 Oct; 262(10):2275-84. PubMed ID: 26159102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in fatigue after bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Chou KL; Persad CC; Patil PG
    Parkinsonism Relat Disord; 2012 Jun; 18(5):510-3. PubMed ID: 22341622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measuring Subthalamic Nucleus Volume of Parkinson's Patients and Evaluating Its Relationship with Clinical Scales at Pre- and Postdeep Brain Stimulation Treatment: A Magnetic Resonance Imaging Study.
    Lu L; Xu K; Shi L; Dou W; Liu K; Ma H; Xie L; Zhang C; Lu C
    Biomed Res Int; 2021; 2021():6646416. PubMed ID: 33708991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.